Breast Cancer: Evolving Science, Care, Equity
*Corresponding Author: Laura Stein, Berlin Cancer Science Institute, Germany, Email: laura.stein@berlincancer.deReceived Date: Nov 01, 2025 / Accepted Date: Dec 01, 2025 / Published Date: Dec 01, 2025
Citation: Stein L (2025) Breast Cancer: Evolving Science, Care, Equity. jcd 09: 323.DOI: 10.4172/2476-2253.1000323
Copyright: © 2025 Laura Stein This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
This compilation highlights recent advancements and ongoing challenges in breast cancer. It covers tailoring treatments for spe
cific subtypes like HER2-low, HER2-positive, and triple-negative breast cancer, along with precision medicine and immunotherapy
approaches. The collection also examines screening guidelines, management of ductal carcinoma in situ, and considerations for male
breast cancer. Further, it addresses health-related quality of life for survivors and persistent socioeconomic disparities, emphasizing
the continuous evolution of diagnostic and therapeutic strategies towards improved patient outcomes and health equity across diverse
populations.
